Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

SML3026

Sigma-Aldrich

BAY-786

≥98% (HPLC)

Synonym(s):

(2R)-N-[[3-Chloro-5-(trifluoromethyl)-2-pyridyl]methyl]-2-cyclopropyl-1-(4-fluorophenyl)sulfonyl-1′,1′-dioxo-spiro[indoline-3,4′-thiane]-5-carboxamide, (2R)-N-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]methyl]-2-cyclopropyl-1-[(4-fluorophenyl)sulfonyl]-1,2,2,3,5,6-hexahydro-spiro[3H-indole-3,4-[4H]thiopyran]-5-carboxamide 1,1-dioxide

Sign Into View Organizational & Contract Pricing

Select a Size

5 ML
$286.00
10 ML
$332.50

$286.00


In StockDetails


Request a Bulk Order

Select a Size

Change View
5 ML
$286.00
10 ML
$332.50

About This Item

Empirical Formula (Hill Notation):
C29H26ClF4N3O5S2
CAS Number:
Molecular Weight:
672.11
UNSPSC Code:
12352200
NACRES:
NA.77

$286.00


In StockDetails


Request a Bulk Order

Quality Level

assay

≥98% (HPLC)

form

powder

optical activity

[α]/D 105 to 125°, c = 0.5 in chloroform-d

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C(C1=CC2=C(N(S(=O)(C3=CC=C(F)C=C3)=O)[C@H](C4CC4)C2(CC5)CCS5(=O)=O)C=C1)NCC6=NC=C(C(F)(F)F)C=C6Cl

InChI key

PZGSYNNVPNLHQG-AREMUKBSSA-N

Biochem/physiol Actions

BAY-786 is a negative control for an orally available, non-toxic, potent, and selective GnRH-R antagonist BAY-784.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


  • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Olaf Panknin et al.
    Journal of medicinal chemistry, 63(20), 11854-11881 (2020-09-23)
    The growth of uterine fibroids is sex hormone-dependent and commonly associated with highly incapacitating symptoms. Most treatment options consist of the control of these hormonal effects, ultimately blocking proliferative estrogen signaling (i.e., oral contraceptives/antagonization of human gonadotropin-releasing hormone receptor [hGnRH-R]

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service